全文获取类型
收费全文 | 2456篇 |
免费 | 199篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 61篇 |
妇产科学 | 65篇 |
基础医学 | 356篇 |
口腔科学 | 21篇 |
临床医学 | 296篇 |
内科学 | 448篇 |
皮肤病学 | 61篇 |
神经病学 | 273篇 |
特种医学 | 39篇 |
外科学 | 287篇 |
综合类 | 24篇 |
一般理论 | 5篇 |
预防医学 | 319篇 |
眼科学 | 41篇 |
药学 | 197篇 |
中国医学 | 4篇 |
肿瘤学 | 129篇 |
出版年
2023年 | 36篇 |
2022年 | 31篇 |
2021年 | 146篇 |
2020年 | 94篇 |
2019年 | 144篇 |
2018年 | 174篇 |
2017年 | 93篇 |
2016年 | 97篇 |
2015年 | 107篇 |
2014年 | 142篇 |
2013年 | 146篇 |
2012年 | 221篇 |
2011年 | 249篇 |
2010年 | 121篇 |
2009年 | 110篇 |
2008年 | 158篇 |
2007年 | 137篇 |
2006年 | 105篇 |
2005年 | 87篇 |
2004年 | 63篇 |
2003年 | 59篇 |
2002年 | 37篇 |
2001年 | 9篇 |
2000年 | 5篇 |
1999年 | 7篇 |
1998年 | 8篇 |
1997年 | 2篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 11篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 8篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1973年 | 2篇 |
1970年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有2660条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Ann Iverson Larissa I. Stanberry Peter Tajti Ross Garberich Amber Antos M. Nicholas Burke Ivan Chavez Mario Gössl Timothy D. Henry Daniel Lips Michael Mooney Anil Poulose Paul Sorajja Jay Traverse Yale Wang Steven Bradley Emmanouil S. Brilakis 《Cardiovascular Revascularization Medicine》2019,20(4):289-292
Background/purpose
Patients and lesions at a higher procedural risk for percutaneous coronary intervention (PCI) are an understudied population. We examined the frequency, clinical characteristics, and outcomes of higher risk and non-higher risk PCIs at a large tertiary center.Methods/materials
The following procedures were considered higher risk: unprotected left main PCI, chronic total occlusion PCI, PCI requiring atherectomy, multivessel PCI, bifurcation PCI, PCI in prior coronary artery bypass graft surgery (CABG) patients, pre-PCI left ventricular ejection fraction ≤30%, or use of hemodynamic support.Results
Of the 1975 PCIs performed from 6/29/09 to 12/30/2016 in patients without acute coronary syndromes, 1230 (62%) were higher risk. Patients undergoing higher risk PCI were more likely to have a history of CABG, myocardial infarction, PCI, cerebrovascular disease, peripheral arterial disease, or congestive heart failure. Higher risk PCIs required more stents (2.0 vs. 1.0, p?<?0.001), and had longer median fluoroscopy times (17.3 vs. 8.5?min, p?<?0.001) and higher median contrast doses (160 vs. 120?mL, p?<?0.001). In higher risk PCIs, the risks for technical failure and periprocedural complications were 2.9 (95% CI 1.2–7.4) times and 2.2 (95% CI 0.9–5.4) times higher as compared with non-higher risk PCI procedures.Conclusions
In summary, over half of the PCIs performed in non-acute coronary syndrome patients were higher risk and were associated with lower odds of technical success and higher periprocedural complication rates as compared with non-higher risk PCIs.Summary
We examined the frequency, clinical characteristics, and outcomes of higher risk and non-higher risk PCIs at a large tertiary center. Higher risk PCI was associated with lower odds of technical and procedural success and higher odds of procedural complications as compared with non-higher risk PCI. However, the risk/benefit ratio may still be favorable for many of these higher-risk patients and should be estimated on a case by case basis. 相似文献5.
Brad Wright PhD Canada Parrish PhD MSPH Anirban Basu PhD MS Karen E. Joynt Maddox MD MPH Joshua M. Liao MD. MSc Amber K. Sabbatini MD MPH 《Health services research》2023,58(3):554-559
Objective
To evaluate whether Medicare's Hospital Readmissions Reduction Program (HRRP) is associated with increased observation stay use.Data Sources and Study Setting
A nationally representative sample of fee-for-service Medicare claims, January 2009–September 2016.Study Design
Using a difference-in-difference (DID) design, we modeled changes in observation stays as a proportion of total hospitalizations, separately comparing the initial (acute myocardial infarction, pneumonia, heart failure) and subsequent (chronic obstructive pulmonary disease) target conditions with a control group of nontarget conditions. Each model used 3 time periods: baseline (15 months before program announcement), an intervening period between announcement and implementation, and a 2-year post-implementation period, with specific dates defined by HRRP policies.Data Collection/Extraction Methods
We derived a 20% random sample of all hospitalizations for beneficiaries continuously enrolled for 12 months before hospitalization (N = 7,162,189).Principal Findings
Observation stays increased similarly for the initial HRRP target and nontarget conditions in the intervening period (0.01% points per month [95% CI −0.01, 0.3]). Post-implementation, observation stays increased significantly more for target versus nontarget conditions, but the difference is quite small (0.02% points per month [95% CI 0.002, 0.04]). Results for the COPD analysis were statistically insignificant in both policy periods.Conclusions
The increase in observation stays is likely due to other factors, including audit activity and clinical advances. 相似文献6.
7.
8.
Pranshuta Sabharwal Sangeeta Chakraborty Niraj Tyagi Amber Kumar 《Indian Journal of Critical Care Medicine》2021,25(2):238
How to cite this article: Sabharwal P, Chakraborty S, Tyagi N, Kumar A. Acute Flaccid Quadriparesis in a Recovering COVID-19 Patient: A Clinical Dilemma. Indian J Crit Care Med 2021;25(2):238–239. 相似文献
9.
Sheean Patricia Gomez-Perez Sandra Joyce Cara O’Connor Paula Bojko Monica Smith Amber Vasilopoulos Vasilios Rao Ruta Sclamberg Joy Robinson Patricia 《Breast cancer research and treatment》2021,190(1):121-132
Breast Cancer Research and Treatment - To examine the relationship between skeletal muscle (SM) and cancer-specific outcomes for women with estrogen receptor-negative (ER?) metastatic breast... 相似文献
10.
Erin M. Warshaw Lindsey M. Voller Howard I. Maibach Kathryn A. Zug Joel G. DeKoven Amber R. Atwater Margo J. Reeder Denis Sasseville James S. Taylor Joseph F. Fowler Melanie D. Pratt Jonathan I. Silverberg Anthony F. Fransway Matthew J. Zirwas Donald V. Belsito James G. Marks Vincent A. DeLeo 《Journal of the American Academy of Dermatology》2021,84(4):953-964